LYMPHACT
Lymphact is a biopharmaceutical start-up focused on developing innovative personalized medical treatments. Their products and technologies are designed to harness the power of the immune system, the target-specific cellular mechanism which evolved in vertebrates during the last 450 million years, towards a permanent elimination of pathogens. After 5 years of pioneering research and development in this field, they created a new technology platform which can generate autologous and allogeneic cellular immune therapies for clinical applications: DOT-Cells®.
LYMPHACT
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2013-01-01
Address:
Évora, Evora, Portugal
Country:
Portugal
Website Url:
http://www.lymphact.com
Total Employee:
1+
Status:
Active
Total Funding:
357.74 K USD
Technology used in webpage:
SPF Amazon IPv6 Amazon Route 53 AWS Global Accelerator
Founder
Investors List
Bynd Venture Capital
Bynd Venture Capital investment in Seed Round - Lymphact
Portugal Ventures
Portugal Ventures investment in Seed Round - Lymphact
Newest Events participated
Participated in Web Summit 2017
on 2017-11-06 as exhibitor
Official Site Inspections
http://www.lymphact.com
- Host name: afe41c95a9e82f02c.awsglobalaccelerator.com
- IP address: 13.248.133.121
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
